Raising the Bar on Leadership for the Evolving CFO/Financial Executive

July 9, 2020 8:00 AM - 9:00 AM

Webinar, click "live-stream" button to view

Add to Calendar 7/9/2020 8:00:00 AM 7/9/2020 9:00:00 AM Raising the Bar on Leadership for the Evolving CFO/Financial Executive

Within the life science eco-system, the role of the CFO/financial executive continues to shift. CFOs and financial executives are assuming increasingly complex roles, from managing day-to-day responsibilities, to driving value creation across the business, to navigating the markets and volatility. As a ‘strategic partner’ to the CEO, CFOs/financial executives must master the art of balance and agility with appropriate skills, talents, experiences and support.


To start, below are five key characteristics that exemplify the evolving life science CFO/financial executive:

  • Holistic perspective encompassing the entire value chain
  • Insight and ability to communicate business drivers
  • Eye for the right kind of talent
  • Facility for cultural change
  • Integrity and interpersonal skills needed to pull all these together


How can you become a finance leader and recruit those who will support and succeed you? What should emerging finance leaders think about as they step into the CFO/financial executive role? Or for the seasoned executive who is taking on their 2nd or 3rd role, what should you keep in mind to ensure your ability to consistently lead with success?

Join us as we draw on the wisdom of our panelists to understand and discuss the art and expertise of today’s ‘successful, cross functional’ life science CFO/financial executive. Sponsored by the MassBio Business Development and Finance forum working group. MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Webinar, click "live-stream" button to view
Chief Financial Officer, Beam Therapeutics
Terry-Ann Burrell, a financial industry veteran, is Chief Financial Officer of Beam. Prior to Beam, Ms. Burrell spent 11 years with J.P. Morgan, most recently as a Managing Director in the healthcare investment banking group. There, she had broad coverage across the biotechnology and pharmaceutical industries, helping to execute over $10 billion in equity and equity linked financings and more than $50 billion in M&A transactions. She was instrumental in advising clients on transaction considerations, including strategic rationale, valuation and structuring, and engaged with more than 100 companies during her tenure. Prior to J.P. Morgan, Ms. Burrell worked in equity research at Citigroup, where she covered specialty pharmaceuticals and generics. Ms. Burrell holds an MBA from New York University Leonard N. Stern School of Business and a B.A. from Harvard University.